20536395|t|Pharmacogenetic features of cathepsin B inhibitors that improve memory deficit and reduce beta-amyloid related to Alzheimer's disease.
20536395|a|Beta-amyloid (Abeta) in the brain is a major factor involved in Alzheimer's disease (AD) that results in severe memory deficit. Our recent studies demonstrate pharmacogenetic differences in the effects of inhibitors of cathepsin B to improve memory and reduce Abeta in different mouse models of AD. The inhibitors improve memory and reduce brain Abeta in mice expressing the wild-type (WT) beta-secretase site of human APP, expressed in most AD patients. However, these inhibitors have no effect in mice expressing the rare Swedish (Swe) mutant amyloid precursor protein (APP). Knockout of the cathepsin B decreased brain Abeta in mice expressing WT APP, validating cathepsin B as the target. The specificity of cathepsin B to cleave the WT beta-secretase site, but not the Swe mutant site, of APP for Abeta production explains the distinct inhibitor responses in the different AD mouse models. In contrast to cathepsin B, the BACE1 beta-secretase prefers to cleave the Swe mutant site. Discussion of BACE1 data in the field indicate that they do not preclude cathepsin B as also being a beta-secretase. Cathepsin B and BACE1 could participate jointly as beta-secretases. Significantly, the majority of AD patients express WT APP and, therefore, inhibitors of cathepsin B represent candidate drugs for AD.
20536395	28	39	cathepsin B	Gene	1508
20536395	64	78	memory deficit	Disease	MESH:D008569
20536395	114	133	Alzheimer's disease	Disease	MESH:D000544
20536395	149	154	Abeta	Gene	351
20536395	199	218	Alzheimer's disease	Disease	MESH:D000544
20536395	220	222	AD	Disease	MESH:D000544
20536395	247	261	memory deficit	Disease	MESH:D008569
20536395	354	365	cathepsin B	Gene	13030
20536395	395	400	Abeta	Gene	11820
20536395	414	419	mouse	Species	10090
20536395	430	432	AD	Disease	MESH:D000544
20536395	481	486	Abeta	Gene	11820
20536395	490	494	mice	Species	10090
20536395	548	553	human	Species	9606
20536395	577	579	AD	Disease	MESH:D000544
20536395	580	588	patients	Species	9606
20536395	634	638	mice	Species	10090
20536395	680	705	amyloid precursor protein	Gene	11820
20536395	729	740	cathepsin B	Gene	13030
20536395	757	762	Abeta	Gene	11820
20536395	766	770	mice	Species	10090
20536395	801	812	cathepsin B	Gene	13030
20536395	847	858	cathepsin B	Gene	13030
20536395	937	942	Abeta	Gene	11820
20536395	1013	1015	AD	Disease	MESH:D000544
20536395	1016	1021	mouse	Species	10090
20536395	1045	1056	cathepsin B	Gene	13030
20536395	1062	1067	BACE1	Gene	23821
20536395	1136	1141	BACE1	Gene	23821
20536395	1195	1206	cathepsin B	Gene	13030
20536395	1239	1250	Cathepsin B	Gene	13030
20536395	1255	1260	BACE1	Gene	23821
20536395	1338	1340	AD	Disease	MESH:D000544
20536395	1341	1349	patients	Species	9606
20536395	1395	1406	cathepsin B	Gene	1508
20536395	1437	1439	AD	Disease	MESH:D000544
20536395	Association	MESH:D008569	1508
20536395	Positive_Correlation	MESH:D008569	351
20536395	Association	MESH:D000544	1508
20536395	Positive_Correlation	11820	13030
20536395	Association	MESH:D000544	351

